Form D · Biotechnology
XHALE DIAGNOSTICS INC
Gainesville, FL · CIK 0001377008
Offering snapshot reported May 26, 2009 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1.5M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 26, 2009 | Amendment | Yet to sell | No comparison | Not reported | SEC filing |
| May 19, 2009 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
| Sep 10, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-95274
Source: Form D, filed May 26, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Allen | Promoter |
| Louis Raymond Cabana | Executive |
| Donn Dennis | Executive |
| David Dizney | Director |
| Mark S. Gold | Director |
| S. Tucker Johnson | Director |
| Richard J. Melker | Executive |
| Jack Wilkens | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
101 S E 2 Nd Place Ste 201 A
Gainesville, FL, 32601
Gainesville, FL, 32601